QuidelOrtho Corporation Common Stock (QDEL) — Analysis Summary
QuidelOrtho Corporation Common Stock (QDEL) has a market cap of $887.85M with year-over-year revenue growth of -1.9%. Net margin stands at -41.5%. The stock trades at a P/E ratio of -0.7.
Key Takeaways
- Revenue changed -1.9% year-over-year
- Net margin of -41.5%
- P/E ratio of -0.7
Compared to other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, QDEL posted revenue growth of -1.9% and trades at a P/E of -0.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.